World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
68395
World Ranking
6891
National Ranking
3635

Maura L. Gillison publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Maura L. Gillison sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 474 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Maura L. Gillison D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Maura L. Gillison sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 104 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Maura L. Gillison is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily falls within the field of medicine, with a significant focus on oncology.

Their work addresses several subfields, including:

  • Oncology
  • Otorhinolaryngology
  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Surgery

Gillison's main research topics include:

  • Head and Neck Cancer Studies
  • Cancer Immunotherapy and Biomarkers
  • Cervical Cancer and HPV Research
  • Lung Cancer Treatments and Mutations
  • Colorectal and Anal Carcinomas
  • Lung Cancer Research Studies
  • CAR-T cell therapy research

The scientist has contributed to multiple papers, including recent notable publications such as:

  • Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology (2020), Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022 (2022), Journal of the National Comprehensive Cancer Network
  • Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance (2023), Nature Medicine
  • Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002) (2021), Journal of Clinical Oncology
  • Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States (2023), Journal of Clinical Oncology

Frequent co-authors in their work include:

  • Weihong Xiao
  • Neil D. Gross
  • Bo Jiang
  • Jimmy J. Caudell
  • Adam S. Garden

Gillison's research has appeared most frequently in the following publication venues:

  • Journal of Clinical Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Regular and Young Investigator Award Abstracts
  • Annals of Oncology
  • Clinical Cancer Research

Best Publications

  • Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

    K Kian Ang;Jonathan Harris;Richard Wheeler;Randal Weber

  • Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

    Robert L. Ferris;George Blumenschein;Jerome Fayette;Joel Guigay

  • Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

    Anil K. Chaturvedi;Eric A. Engels;Ruth M. Pfeiffer;Brenda Y. Hernandez

  • Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers

    Maura Gillison;Wayne M. Koch;Randolph B. Capone;Michael Spafford

  • Case-control study of human papillomavirus and oropharyngeal cancer.

    Aimee R. Kreimer;Raphael Viscidi;Michael Pawlita;Carole Fakhry

  • Improved Survival of Patients With Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial

    Carole Fakhry;William H. Westra;Sigui Li;Anthony Cmelak

  • Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Cancers

    Maura L. Gillison;Gypsyamber D'Souza;William Westra;Elizabeth Sugar

  • Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United States

    Anil K. Chaturvedi;Eric A. Engels;William F. Anderson;Maura L. Gillison

  • Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers

    Anil K. Chaturvedi;William F. Anderson;Joannie Lortet-Tieulent;Maria Paula Curado

  • Prevalence of oral HPV infection in the United States, 2009-2010.

    Maura L. Gillison;Tatevik Broutian;Robert K. L. Pickard;Zhen-yue Tong

  • Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma

    Maura L. Gillison;Anil K. Chaturvedi;William F. Anderson;Carole Fakhry

  • Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

    Maura L Gillison;Andy M Trotti;Jonathan Harris;Avraham Eisbruch

  • Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

    David G. Pfister;Sharon Spencer;David Adelstein;Douglas Adkins

  • Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522

    K. Kian Ang;Qiang Zhang;David I. Rosenthal;Phuc Felix Nguyen-Tan

  • Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression.

    Robert L. Ferris;George Blumenschein;Jerome Fayette;Joel Guigay

  • Oral Sexual Behaviors Associated with Prevalent Oral Human Papillomavirus Infection

    Gypsyamber D’Souza;Yuri Agrawal;Jane Halpern;Sacared Bodison

  • Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity.

    Maura L. Gillison

  • Comprehensive control of human papillomavirus infections and related diseases.

    F. Xavier Bosch;Thomas R. Broker;David Forman;Anna Barbara Moscicki

  • HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women.

    Maura L. Gillison;Anil K. Chaturvedi;Douglas R. Lowy

  • Head and Neck Cancers, Version 2.2014

    David G. Pfister;Sharon Spencer;David M. Brizel;Barbara Burtness

Frequent Co-Authors

Robert I. Haddad
Robert I. Haddad Harvard University
Robert L. Ferris
Robert L. Ferris University of Pittsburgh
William H. Westra
William H. Westra Icahn School of Medicine at Mount Sinai
David I. Rosenthal
David I. Rosenthal The University of Texas MD Anderson Cancer Center
Randal S. Weber
Randal S. Weber The University of Texas MD Anderson Cancer Center
Kevin J. Harrington
Kevin J. Harrington Royal Marsden NHS Foundation Trust
Arlene A. Forastiere
Arlene A. Forastiere Johns Hopkins University
K. Kian Ang
K. Kian Ang The University of Texas MD Anderson Cancer Center
Quynh-Thu Le
Quynh-Thu Le Stanford University
Joseph A. Califano
Joseph A. Califano University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in pursuing a career in medicine or healthcare but exploring flexible options, there are several pharmacy degree online programs available. These programs allow you to study at your own pace while preparing for a professional role in pharmacy, making them ideal for those balancing work or family commitments.

For those drawn to healthcare administration and technology, earning a him associate degree online offers entry into the growing field of health information management. This pathway focuses on managing patient health records, privacy, and the effective use of health data.

Many students also consider billing and coding classes online to quickly start a career in healthcare administration. These courses prepare you for vital positions in medical offices, clinics, and hospitals, handling essential documentation and insurance processes.

Aspiring advanced practice nurses will benefit from exploring the cheapest online fnp programs, which lead to a rewarding nurse practitioner career. These affordable programs help you advance your nursing education and expand your clinical skills while accommodating your current schedule.

Best Scientists Citing Maura L. Gillison

Trending Scientists

Recently Published Articles